News

Charles Wren Brings Hope to Arvin

October 30, 2023 Comments Off on Charles Wren Brings Hope to Arvin

Charles Wren has been living in Arvin for 53 years, and has always been committed to giving back to the community. “We’ve always felt comfortable because Arvin is our home,”…

BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn® for the Treatment of ALS

October 24, 2023 Comments Off on BrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn® for the Treatment of ALS

–  Resource consumption will be reduced by 50% to accelerate ALS development –  Plans underway for registrational Phase 3b U.S. clinical trial for NurOwn in ALS NEW YORK, Oct. 24,…

FDA Advisory Committee holds discussion on NurOwn

September 29, 2023 Comments Off on FDA Advisory Committee holds discussion on NurOwn

On Wednesday, September 27, the Federal Drug Administration hosted a public Advisory Committee (AdCom) to review the approval of NurOwn (Debamestrocel) for the treatment of ALS.  Developed by Brainstorm Cell…

A special message about the Hawaii fires and the ALS community

August 22, 2023 Comments Off on A special message about the Hawaii fires and the ALS community

In the past few weeks, individuals and families in Hawaii have experienced devastating wildfires that have claimed more than 110 lives to date while more than 1,000 people remain missing.…

A special announcement from Golden West Leadership

July 6, 2023 Comments Off on A special announcement from Golden West Leadership

As a valued member of our ALS community, we have important news to share with you on behalf of our Board of Directors and leadership team. As of September 1,…

No one left behind: ALS Clinic uncovers racial disparities in diagnostic delays

April 20, 2023 Comments Off on No one left behind: ALS Clinic uncovers racial disparities in diagnostic delays

Researchers at the VCU Health ALS Clinic found that Black patients in Virginia experienced longer delays to being diagnosed with ALS than white patients. Now, they are focused on finding…